Greenwich LifeSciences reported Q4 2024 revenue of $3.6K. Diluted EPS came in at $-0.61, missed the $-0.21 consensus by $0.40.
Filings will appear here once submitted to SEC EDGAR.
Common questions about Greenwich LifeSciences's Q4 2024 earnings report.
Greenwich LifeSciences (GLSI) reported Q4 2024 earnings on April 15, 2025 before market open.
Greenwich LifeSciences reported revenue of $3.6K and diluted EPS of $-0.61 for Q4 2024.
EPS missed the consensus estimate of $-0.21 by $0.40.